Review



edta plasma tissue plasminogen activator tpa molecular innovations ipctpakta  (Innovative Research Inc)


Bioz Verified Symbol Innovative Research Inc is a verified supplier
Bioz Manufacturer Symbol Innovative Research Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Innovative Research Inc edta plasma tissue plasminogen activator tpa molecular innovations ipctpakta
    Edta Plasma Tissue Plasminogen Activator Tpa Molecular Innovations Ipctpakta, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 92/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plasminogen+activator+inhibitor+1/Porcine+Active+PAI-1+ELISA+Kit%2CPorcine+PAI-1+Activity+ELISA+Kit/pm41693475-83-81-87
    Average 92 stars, based on 12 article reviews
    edta plasma tissue plasminogen activator tpa molecular innovations ipctpakta - by Bioz Stars, 2026-10
    92/100 stars

    Images

    Related Articles

    Western Blot:

    Article Title: Elevated Expression of Vascular Adhesion Molecule-1, Plasminogen Activator Inhibitor-1, Cyclooxygenase-2, and Thrombomodulin in Human Umbilical Vein Endothelial Cells from Hospitalized Gestational Diabetes Mellitus Patients.
    Article Snippet: The membrane was blocked for 1 h with 25 mM Tris-buffered saline (TBS) containing 0.5% or 1% skim milk (Wako) and 0.05% Tween 20 (Wako). .. Immunoblotting analysis was performed with specific antibodies directed against intercellular adhesion molecule-1 (ICAM-1; #4915; Cell Signaling Technology, Danvers, MA, U.S.A.), endothelial nitric oxide synthase (eNOS; 610296; BD Biosciences, San Diego, CA, U.S.A.), thrombomodulin (TM; #HPA002982; Sigma-Aldrich), vascular adhesion molecule-1 (VCAM-1; sc-1504; Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.), plasminogen activator inhibitor-1 (PAI-1; #ASHPAI-GF; Molecular Innovations, Novi, MI, U.S.A.), cyclooxygenase-2 (COX-2; Cayman Chemical, Ann Arbor, MI, U.S.A.), VE-cadherin (#2500; Cell Signaling Technology), and β-actin (#4967; Cell Signaling Technology). .. The membrane was washed with 0.05% Tween 20–TBS and incubated with anti-rabbit (#7074; Cell Signaling Technology) or anti-mouse (A9044; Sigma-Aldrich) immunoglobulin G antibody coupled with horseradish peroxidase.

    Article Title: Inhibition of Glycogen Synthase Kinase 3β Blocks Mesomesenchymal Transition and Attenuates Streptococcus pneumonia –Mediated Pleural Injury in Mice
    Article Snippet: Serum-starved PMCs were treated with 5 ng/mL transforming growth factor (TGF)-β (R&D Systems), 20 nmol/L uPA (Sekisui, Lexington, MA), and 7 nmol/L plasmin (Molecular Innovations, Southfield, MI). .. Cell lysates and conditioned media then underwent Western blot analysis for α-SMA (MAB1420; R&D Systems), Col-1 (1310-08; Southern Biotech, Birmingham, AL), plasminogen activator inhibitor-1 (PAI3C311; Molecular Innovations), total GSK-3β (12456; Cell Signaling), phosphorylated Tyr-216-GSK-3β (sc-135653; Santa Cruz Biotechnology, Santa Cruz, CA), total SMAD2 and phosphorylated SMAD2 (11958S; Cell Signaling), and β-actin (A1978; Sigma-Aldrich) as previously described. ..

    Enzyme-linked Immunosorbent Assay:

    Article Title: Oral Supplementation of Glutamine Attenuates the Progression of Nonalcoholic Steatohepatitis in C57BL/6J Mice.
    Article Snippet: .. Commercially available mouse TNF-a (Assaypro), plasminogen activator inhibitor 1 [PAI1 (Molecular Innovations)], or IL-6 ELISA kits (RayBio) were used according to the instructions of the manufacturer to determine the concentrations of these proteins in liver homogenates. .. For total glutathione measurement, a glutathione assay kit (Cayman) was used according to the instructions of the manufacturer.

    Article Title: Monocyte chemotactic protein-1 deficiency reduces spontaneous metastasis of Lewis lung carcinoma in mice fed a high-fat diet
    Article Snippet: .. Concentrations of plasminogen activator inhibitor-1 (PAI-1, Molecular Innovations, Inc., Novi, MI), insulin (Mercodia, Inc., Winston Salem, NC), tumor necrosis factor-α (TNF-α), leptin, vascular endothelial growth factor (VEGF) and tissue inhibitor of metalloproteinase-1 (TIMP-1, R&D Systems, Minneapolis, MN) in plasma were quantified by using ELISA kits following manufacturers' protocols. ..

    Clinical Proteomics:

    Article Title: Monocyte chemotactic protein-1 deficiency reduces spontaneous metastasis of Lewis lung carcinoma in mice fed a high-fat diet
    Article Snippet: .. Concentrations of plasminogen activator inhibitor-1 (PAI-1, Molecular Innovations, Inc., Novi, MI), insulin (Mercodia, Inc., Winston Salem, NC), tumor necrosis factor-α (TNF-α), leptin, vascular endothelial growth factor (VEGF) and tissue inhibitor of metalloproteinase-1 (TIMP-1, R&D Systems, Minneapolis, MN) in plasma were quantified by using ELISA kits following manufacturers' protocols. ..

    Article Title: REBOA for the Treatment of Blast Polytrauma: Zone 3 Provides Cerebral Perfusion, Attenuates Organ Dysfunction and Reperfusion Coagulopathy Compared to Zone 1 in a Swine Model
    Article Snippet: mitted: August 17, 20 Published online: Feb m the Department of M.J.C., C.C.S.), Scho Shock Trauma Center Systems, Managemen Colorado Denver, Au Albert Einstein (P.H.C University of Colorad Department of Pediat Denver, Aurora; Vita Department of Vascu Maryland, Baltimore plemental digital conte the printed text, and lin article on the journal’s dress for corresponden Moore Shock Trauma Denver, CO 80204; em

    Article Title: Comparison of changes in blood cells and hemostatic biomarkers in mouse xenograft models of acute myeloid leukemia and acute promyelocytic leukemia
    Article Snippet: .. Levels of different biomarkers in plasma were measured using commercial enzyme-linked immunosorbent assays: TAT (Siemens, cat number OWMG15), fibrinogen (Immunology Consultation Laboratory Inc, cat number E-90FIB), PAP (MyBioSource, cat number MBS2512896), D-dimer (Diagnostica Stago, cat number 00947), and plasminogen activator inhibitor 1 (PAI-1; Molecular Innovations, cat number IMSPAI1KTA). cfDNA was measured using the Quant-iT PicoGreen dsDNA Assay Kit (Thermo Fisher Scientific, cat number P11496). ..

    Picogreen Assay:

    Article Title: Comparison of changes in blood cells and hemostatic biomarkers in mouse xenograft models of acute myeloid leukemia and acute promyelocytic leukemia
    Article Snippet: .. Levels of different biomarkers in plasma were measured using commercial enzyme-linked immunosorbent assays: TAT (Siemens, cat number OWMG15), fibrinogen (Immunology Consultation Laboratory Inc, cat number E-90FIB), PAP (MyBioSource, cat number MBS2512896), D-dimer (Diagnostica Stago, cat number 00947), and plasminogen activator inhibitor 1 (PAI-1; Molecular Innovations, cat number IMSPAI1KTA). cfDNA was measured using the Quant-iT PicoGreen dsDNA Assay Kit (Thermo Fisher Scientific, cat number P11496). ..



    Similar Products

    94
    Bio-Techne corporation human serpin e1/pai-1 quantikine elisa kit
    Human Serpin E1/Pai 1 Quantikine Elisa Kit, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plasminogen+activator+inhibitor+1/Human+Serpin+E1%2FPAI-1+Quantikine+ELISA+Kit/bio-techne+corporation___dse100
    Average 94 stars, based on 1 article reviews
    human serpin e1/pai-1 quantikine elisa kit - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    R&D Systems plasminogen activator inhibitor type 1 pai 1 kit
    Plasminogen Activator Inhibitor Type 1 Pai 1 Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plasminogen+activator+inhibitor+1/Mouse+Serpin+E1%2FPAI-1+DuoSet+ELISA/pm41917468-33-23-33
    Average 94 stars, based on 1 article reviews
    plasminogen activator inhibitor type 1 pai 1 kit - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    Elabscience Biotechnology human pai 1 sandwich elisa kit
    Human Pai 1 Sandwich Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plasminogen+activator+inhibitor+1/Human+PAI1+(Plasminogen+Activator+Inhibitor+1)+ELISA+Kit/pm41744606-77-11-17
    Average 94 stars, based on 1 article reviews
    human pai 1 sandwich elisa kit - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    92
    Innovative Research Inc edta plasma tissue plasminogen activator tpa molecular innovations ipctpakta
    Edta Plasma Tissue Plasminogen Activator Tpa Molecular Innovations Ipctpakta, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plasminogen+activator+inhibitor+1/Porcine+Active+PAI-1+ELISA+Kit%2CPorcine+PAI-1+Activity+ELISA+Kit/pm41693475-83-81-87
    Average 92 stars, based on 1 article reviews
    edta plasma tissue plasminogen activator tpa molecular innovations ipctpakta - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    92
    Innovative Research Inc edta plasma plasminogen activator inhibitor 1 pai 1 molecular innovations
    Edta Plasma Plasminogen Activator Inhibitor 1 Pai 1 Molecular Innovations, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plasminogen+activator+inhibitor+1/Porcine+Active+PAI-1+ELISA+Kit%2CPorcine+PAI-1+Activity+ELISA+Kit/pm41693475-83-72-78
    Average 92 stars, based on 1 article reviews
    edta plasma plasminogen activator inhibitor 1 pai 1 molecular innovations - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    94
    Innovative Research Inc plasminogen activator inhibitor 1
    Hemostatic biomarkers in mouse models of acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL). Levels of hemostatic biomarkers in control mice and mice bearing NB4-Luc cells (APL) or HL-60-Luc2 cells (AML) for (A) cell-free DNA (cfDNA), (B) thrombin-antithrombin complexes (TAT), (C) fibrinogen, (D) plasmin-antiplasmin complexes (PAP), (E) D-dimer, and (F) plasminogen activator <t>inhibitor</t> <t>1</t> (PAI-1). Control ( n = 7-9), APL mice ( n = 6 at 28 [ n = 2] or 31 [ n = 4] days for cfDNA, TAT and D-dimer, n = 7 at 29 [ n = 1] or 31 [ n = 6] days for fibrinogen, PAP, and PAI-1), and AML mice ( n = 9 at 45 [ n = 2], 48 [ n = 2], or 50 [ n = 5] days for cfDNA, TAT, and D-dimer. n = 6 at 51 days for fibrinogen, PAP, and PAI-1) are shown. (B, C, E, and F) An ordinary one-way anova followed by Tukey’s test was used for TAT, fibrinogen, D-dimer, and PAI-1; (A and D) the Kruskal–Wallis test followed by Dunn’s test was used for cfDNA and PAP. ∗ P < .05; ∗∗ P < .01; ∗∗∗∗ P < .0001.
    Plasminogen Activator Inhibitor 1, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plasminogen+activator+inhibitor+1/Mouse+Active+PAI-1+ELISA+Kit%2CMouse+PAI-1+Activity+ELISA+Kit/pmc12829123-47-38-43
    Average 94 stars, based on 1 article reviews
    plasminogen activator inhibitor 1 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    93
    Cusabio dog plasminogen activator inhibitor 1 serpine1 elisa kit
    Hemostatic biomarkers in mouse models of acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL). Levels of hemostatic biomarkers in control mice and mice bearing NB4-Luc cells (APL) or HL-60-Luc2 cells (AML) for (A) cell-free DNA (cfDNA), (B) thrombin-antithrombin complexes (TAT), (C) fibrinogen, (D) plasmin-antiplasmin complexes (PAP), (E) D-dimer, and (F) plasminogen activator <t>inhibitor</t> <t>1</t> (PAI-1). Control ( n = 7-9), APL mice ( n = 6 at 28 [ n = 2] or 31 [ n = 4] days for cfDNA, TAT and D-dimer, n = 7 at 29 [ n = 1] or 31 [ n = 6] days for fibrinogen, PAP, and PAI-1), and AML mice ( n = 9 at 45 [ n = 2], 48 [ n = 2], or 50 [ n = 5] days for cfDNA, TAT, and D-dimer. n = 6 at 51 days for fibrinogen, PAP, and PAI-1) are shown. (B, C, E, and F) An ordinary one-way anova followed by Tukey’s test was used for TAT, fibrinogen, D-dimer, and PAI-1; (A and D) the Kruskal–Wallis test followed by Dunn’s test was used for cfDNA and PAP. ∗ P < .05; ∗∗ P < .01; ∗∗∗∗ P < .0001.
    Dog Plasminogen Activator Inhibitor 1 Serpine1 Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plasminogen+activator+inhibitor+1/SERPINE1/10__17221_slash_16_slash_2025___vetmed-34-38-46
    Average 93 stars, based on 1 article reviews
    dog plasminogen activator inhibitor 1 serpine1 elisa kit - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    86
    Proteostasis Therapeutics plasminogen activator inhibitor 1
    Hemostatic biomarkers in mouse models of acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL). Levels of hemostatic biomarkers in control mice and mice bearing NB4-Luc cells (APL) or HL-60-Luc2 cells (AML) for (A) cell-free DNA (cfDNA), (B) thrombin-antithrombin complexes (TAT), (C) fibrinogen, (D) plasmin-antiplasmin complexes (PAP), (E) D-dimer, and (F) plasminogen activator <t>inhibitor</t> <t>1</t> (PAI-1). Control ( n = 7-9), APL mice ( n = 6 at 28 [ n = 2] or 31 [ n = 4] days for cfDNA, TAT and D-dimer, n = 7 at 29 [ n = 1] or 31 [ n = 6] days for fibrinogen, PAP, and PAI-1), and AML mice ( n = 9 at 45 [ n = 2], 48 [ n = 2], or 50 [ n = 5] days for cfDNA, TAT, and D-dimer. n = 6 at 51 days for fibrinogen, PAP, and PAI-1) are shown. (B, C, E, and F) An ordinary one-way anova followed by Tukey’s test was used for TAT, fibrinogen, D-dimer, and PAI-1; (A and D) the Kruskal–Wallis test followed by Dunn’s test was used for cfDNA and PAP. ∗ P < .05; ∗∗ P < .01; ∗∗∗∗ P < .0001.
    Plasminogen Activator Inhibitor 1, supplied by Proteostasis Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plasminogen+activator+inhibitor+1/1+activator+inhibitor+plasminogen/pmc12620568-612-11-0
    Average 86 stars, based on 1 article reviews
    plasminogen activator inhibitor 1 - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    93
    Innovative Research Inc active plasminogen activator inhibitor 1 pai 1
    Hemostatic biomarkers in mouse models of acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL). Levels of hemostatic biomarkers in control mice and mice bearing NB4-Luc cells (APL) or HL-60-Luc2 cells (AML) for (A) cell-free DNA (cfDNA), (B) thrombin-antithrombin complexes (TAT), (C) fibrinogen, (D) plasmin-antiplasmin complexes (PAP), (E) D-dimer, and (F) plasminogen activator <t>inhibitor</t> <t>1</t> (PAI-1). Control ( n = 7-9), APL mice ( n = 6 at 28 [ n = 2] or 31 [ n = 4] days for cfDNA, TAT and D-dimer, n = 7 at 29 [ n = 1] or 31 [ n = 6] days for fibrinogen, PAP, and PAI-1), and AML mice ( n = 9 at 45 [ n = 2], 48 [ n = 2], or 50 [ n = 5] days for cfDNA, TAT, and D-dimer. n = 6 at 51 days for fibrinogen, PAP, and PAI-1) are shown. (B, C, E, and F) An ordinary one-way anova followed by Tukey’s test was used for TAT, fibrinogen, D-dimer, and PAI-1; (A and D) the Kruskal–Wallis test followed by Dunn’s test was used for cfDNA and PAP. ∗ P < .05; ∗∗ P < .01; ∗∗∗∗ P < .0001.
    Active Plasminogen Activator Inhibitor 1 Pai 1, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plasminogen+activator+inhibitor+1/Human+PAI-1+ELISA+Kit%2CStandard+for+the+Human+PAI-1+ELISA+Kit/10__1182_slash_blood___2025___5252-6-17-40
    Average 93 stars, based on 1 article reviews
    active plasminogen activator inhibitor 1 pai 1 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    Image Search Results


    Hemostatic biomarkers in mouse models of acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL). Levels of hemostatic biomarkers in control mice and mice bearing NB4-Luc cells (APL) or HL-60-Luc2 cells (AML) for (A) cell-free DNA (cfDNA), (B) thrombin-antithrombin complexes (TAT), (C) fibrinogen, (D) plasmin-antiplasmin complexes (PAP), (E) D-dimer, and (F) plasminogen activator inhibitor 1 (PAI-1). Control ( n = 7-9), APL mice ( n = 6 at 28 [ n = 2] or 31 [ n = 4] days for cfDNA, TAT and D-dimer, n = 7 at 29 [ n = 1] or 31 [ n = 6] days for fibrinogen, PAP, and PAI-1), and AML mice ( n = 9 at 45 [ n = 2], 48 [ n = 2], or 50 [ n = 5] days for cfDNA, TAT, and D-dimer. n = 6 at 51 days for fibrinogen, PAP, and PAI-1) are shown. (B, C, E, and F) An ordinary one-way anova followed by Tukey’s test was used for TAT, fibrinogen, D-dimer, and PAI-1; (A and D) the Kruskal–Wallis test followed by Dunn’s test was used for cfDNA and PAP. ∗ P < .05; ∗∗ P < .01; ∗∗∗∗ P < .0001.

    Journal: Research and Practice in Thrombosis and Haemostasis

    Article Title: Comparison of changes in blood cells and hemostatic biomarkers in mouse xenograft models of acute myeloid leukemia and acute promyelocytic leukemia

    doi: 10.1016/j.rpth.2025.103319

    Figure Lengend Snippet: Hemostatic biomarkers in mouse models of acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL). Levels of hemostatic biomarkers in control mice and mice bearing NB4-Luc cells (APL) or HL-60-Luc2 cells (AML) for (A) cell-free DNA (cfDNA), (B) thrombin-antithrombin complexes (TAT), (C) fibrinogen, (D) plasmin-antiplasmin complexes (PAP), (E) D-dimer, and (F) plasminogen activator inhibitor 1 (PAI-1). Control ( n = 7-9), APL mice ( n = 6 at 28 [ n = 2] or 31 [ n = 4] days for cfDNA, TAT and D-dimer, n = 7 at 29 [ n = 1] or 31 [ n = 6] days for fibrinogen, PAP, and PAI-1), and AML mice ( n = 9 at 45 [ n = 2], 48 [ n = 2], or 50 [ n = 5] days for cfDNA, TAT, and D-dimer. n = 6 at 51 days for fibrinogen, PAP, and PAI-1) are shown. (B, C, E, and F) An ordinary one-way anova followed by Tukey’s test was used for TAT, fibrinogen, D-dimer, and PAI-1; (A and D) the Kruskal–Wallis test followed by Dunn’s test was used for cfDNA and PAP. ∗ P < .05; ∗∗ P < .01; ∗∗∗∗ P < .0001.

    Article Snippet: Levels of different biomarkers in plasma were measured using commercial enzyme-linked immunosorbent assays: TAT (Siemens, cat number OWMG15), fibrinogen (Immunology Consultation Laboratory Inc, cat number E-90FIB), PAP (MyBioSource, cat number MBS2512896), D-dimer (Diagnostica Stago, cat number 00947), and plasminogen activator inhibitor 1 (PAI-1; Molecular Innovations, cat number IMSPAI1KTA). cfDNA was measured using the Quant-iT PicoGreen dsDNA Assay Kit (Thermo Fisher Scientific, cat number P11496).

    Techniques: Control